PRAECIS PHARMACEUTICALS INC (PRCS) [Rocket]

In millions, except per share items	Dec-31-05	Dec-31-04	Dec-31-03	Dec-31-02	Dec-31-01	Dec-31-00
	10-K	10-K	10-K	10-K	10-K/A	10-K
Revenues	7.6	3.0	0.0	1.0	59.4	85.9
Revenue growth	154.5%		-100.0%	-98.3%	-30.8%
Cost of goods sold	4.0	1.7	0.0	0.0	59.4	85.9
Gross profit	3.6	1.3	0.0	1.0	0.0	0.0
Gross margin	47.1%	43.0%		100.0%	0.0%	0.0%
Selling, general and administrative [+]	13.0	27.5	15.3	11.5	15.7	11.7
Sales and marketing	6.0	18.9	5.6	1.8	8.7	6.4
General and administrative	7.0	8.7	9.7	9.7	7.0	5.3
Research and development	24.5	31.5	41.8	56.4
Other operating expenses	-1.4				49.5	24.7
EBITDA [+]	-29.9	-53.3	-52.6		-61.7	-31.7
EBITDA growth	-43.8%	1.3%	-21.3%	8.4%	94.6%
EBITDA margin	-393.9%	-1782.8%		-6498.3%	-103.9%	-36.9%
Depreciation and amortization	2.5	4.4	4.6		3.5	4.7
EBIT [+]	-32.5	-57.7	-57.1	-66.9	-65.2	-36.5
EBIT growth	-43.7%	1.0%	-14.5%	2.5%	78.9%
EBIT margin	-427.2%	-1931.2%		-6498.3%	-109.7%	-42.4%
Non-recurring items	30.1
Interest income, net [+]	0.0	0.1	1.3	4.8	9.1	7.8
Interest expense	1.8	1.7	1.2	1.3	1.4	0.4
Interest income	1.7	1.8	2.5	6.1	10.5	8.2
Other income (expense), net	1.4			16.0	1.5
Pre-tax income	-61.2	-57.6	-55.8	-46.1	-54.6	-28.6
Income taxes	0.0	0.0	0.0	0.0	0.0	0.1
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-61.2	-57.6	-55.8	-46.1	-54.6	-28.7
Net margin	-804.7%	-1927.6%		-4477.6%	-91.9%	-33.4%

Basic EPS [+]	($5.83)	($5.51)	($5.38)	($0.89)	($1.10)	($740.73)
Growth	5.9%	2.4%	503.3%	-18.7%	-99.9%
Diluted EPS [+]	($5.83)	($5.51)	($5.38)	($0.89)	($1.10)	($740.73)
Growth	5.9%	2.4%	503.3%	-18.7%	-99.9%

Shares outstanding (basic) [+]	10.5	10.5	10.4	51.7	49.8	0.0
Growth	0.3%	0.8%	-79.9%	3.8%	128211.1%
Shares outstanding (diluted) [+]	10.5	10.5	10.4	51.7	49.8	0.0
Growth	0.3%	0.8%	-79.9%	3.8%	128211.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.